Dingdang Health buys back 0.20 million shares for HK$0.17 million; cumulative repurchases reach 70.05 million shares, 5.31% of share base

Bulletin Express05-27 19:03

Dingdang Health Technology Group Ltd. (Dingdang Health) filed a Next Day Disclosure Return on 27 May 2026, confirming a new on-market share buyback and providing an updated snapshot of its issued share capital.

Key takeaways

1. Latest repurchase • Trading date: 27 May 2026 • Volume: 195,500 ordinary shares, all for cancellation • Price range: HK$0.86–HK$0.89 per share • Cash outlay: HK$0.17 million • Portion of issued shares: 0.015% of the 1,319.47 million shares in issue.

2. Issued share capital remains unchanged • Opening and closing balance (26–27 May 2026): 1,319.47 million shares. • No treasury shares are held.

3. Aggregate repurchases under current mandate • Period covered: 25 Nov 2025–27 May 2026 • Cumulative shares repurchased but not yet cancelled: 70.05 million. • This equals 5.31% of the share count recorded when shareholders approved the mandate on 28 May 2025. • Remaining headroom: approximately 61.89 million shares, or 4.69 percentage points of the original 10% authorisation (131.95 million shares).

4. Moratorium on new issues In line with Main Board Rule 10.06(3)(a), Dingdang Health may not issue new shares until 26 Jun 2026, 30 days after the latest buyback.

The board confirms all repurchases complied with Hong Kong listing rules and applicable regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment